Researchers suggest the decline was linked to countries implementing movement restrictions, which resulted in fewer medical ...
Research and development (R&D) activities are anticipated to drive growth in the adenosine antagonists market by identifying novel therapeutic applications, such as in neurodegenerative diseases, ...
The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.
In other news, HPV vaccine is credited for lower death rate among women under 25; psilocybin is being tested to treat health care worker burnout; and more.
Traumatic brain injury (TBI) is a leading cause of death and disability among young people in the United States and is the most devastating survivable injury in modern warfare, according to the ...
ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia –– ...
Pilot clinical trial explores if early intervention post-brain injury boosts cognitive recovery, aiming to improve outcomes ...
The University of Sunderland has appointed Dr. Mark Shipley as professor of clinical medical education, further enhancing its ...
The COVID-19 pandemic has underscored the critical role of clinical trials in developing effective vaccines and treatments By participating in these trials individuals can contribute significantly to ...